Stereotaxis, Inc.
Medical Devices & Tech  Advamed Member
4320 Forest Park Ave. Suite 100
St. Louis, MO 63108 USA
phone: 866-646-2346
fax: 314-678-6159
Symbol STXS
Exchange Nasdaq
Founded 1990
Employees 140
www.stereotaxis.com
Research Sector Medical Devices & Tech
Summary Description
Cardiology instrument control systems for the interventional treatment of coronary artery disease.
Management
Bevil J. Hogg, President, Chief Executive Officer; Michael P. Kaminski, Chief Operating Officer; James M. Stolze, Chief Financial Officer; Doug Bruce, Senior Vice President, Research and Development; Melissa Walker, MS, RAC, Senior Vice President Regulatory, Quality, and Compliance; Ruchir Sehra, M.D., FACC, Chief Medical Officer
Ownership
Financials Mkt Cap :226


* numbers in thousands

Recent Results
3Q 2006 revenue was $7.6 million, up from the $1.7 million reported for the third quarter of 2005. The company recognized revenue from the sale of seven of its Niobe® advanced cardiology magnetic instrument control systems in the third quarter of 2006.
 
Keywords
Cardiology, cardiac, heart, cardiology, total occlusion, atrial fibrillation, ventricular tachycardia, guiding, instrument control, electrophysiology, coronary artery disease, arrhythmias, magnetic navigation, adv2007, stl, advamed, j2008b

Comment | Printable Version | Oct. 01, 2008
If you work for Stereotaxis, Inc. and want to update this profile, click here

Description
Stereotaxis' proprietary magnetic systems and disposable devices allow physicians to conduct precise, image-guided, computerized remote control interventional procedures.
Products / Services
The Stereotaxis System is a remote-controlled magnetic instrument control and navigation platform that allows physicians to navigate catheters, guidewires and stent delivery devices through the blood vessels and chambers of the heart to treatment sites. The company is not planning to expand its core product portfolio and will instead focus on improving cost and functionality to its existing system.
Technology / Differentiation
The Stereotaxis System uses computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire. This system is the only commercialized technology that allows remote, computerized control of catheters and guidewires directly at their working tip. This represents an important advance in the ongoing trend toward digital instrumentation in the cath lab and provides substantial, clinically important improvements and cost efficiencies over manual interventional methods.
Market / Customers
The system is designed for both routine and complex procedures in electrophysiology and interventional cardiology, including procedures in arrhythmia diagnosis and ablation, cardiac resynchronization therapy and complex occlusion recanalization.
Competitors / Substitutes / Alternatives
The Stereotaxis System has no direct competitors - no other system governs the motion of the catheter or guidewire's working tip through externally applied magnetic fields.
Strategy
Strategic alliances with top established interventional companies, such as Siemens AG Medical Solutions, Philips Medical Systems and Biosense Webster, Inc., a subsidiary of J&J, through which it is integrating the Stereotaxis System with digital imaging and 3D catheter location sensing technology.
Status
Stereotaxis has integrated its products with leading cath lab imaging technologies through alliances with industry leaders. The company's core products have regulatory clearances and approvals in the U.S., Europe and Canada.


2008-10-05-2804